The FDA's stubborn insistence on Taylor Farms as the source of a cyclosporiasis outbreak despite retracted tests raises serious questions about regulatory overreach and the potential for false accusations in the food industry. It's time to question whether the FDA's actions are more about protecting public health or stifling competition.